• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Useful antibacterial agents in which a penicillin and/or a beta-lactamase inhibitor are linked via 1,1-alkanediol dicarboxylates are of the formula where A is the residue of certain dicarboxyic acids, R3 is H or (C1-C3)alkyl, n is zero or 1 such that when n is zero R is P or B and R1 'is the residue of certain esters, H or a salt thereof; and when n is 1, one of R and R1 is P and the other is B, and P is where R2 is H or certain acyl groups, and B is the residue of a beta-lactamase inhibiting carboxylic acid; a method for their use, pharmaceutical compositions thereof and intermediates useful in their production.
    公开号:SU1405704A3
    申请号:SU823529507
    申请日:1982-12-21
    公开日:1988-06-23
    发明作者:Джон Джэсис Витаутас；Стефен Келлогг Майкл
    申请人:Пфайзер Инк (Фирма)；
    IPC主号:
    专利说明:

    tilformamide, or ethyl acetate, or dichloromethane, or acetone at a temperature of from room temperature to 80 ° C, preferably at 25-50 ° C. In the case when X is a benzyloxycarbonylaminogroup, and Q is a 1-methyl-2-methoxycarbonylvinylamino group, in the amino group. The target product is in free form or in the form of pharmaceutically acceptable alkaline or quaternary ammonium salts, z.p., f-lCl I table.
    one
    The invention relates to the field of producing new methylene diol dicarboxylate compounds of the general formula
    R, -C-O- {H, and -
    oa
    K2 (C10CH2) l O
    where A is Cj-Cg-alkylene, a group (CIL) C, cyclohexylene or phenylene; R and R are different and mean when n O R - P or B (a5Bc) 5 R2 is hydrogen or 15 benzyl; with, -P,, while P is a group

    -b
    N - H
    SNS SNZ
    where rj group
    qKjOCH O or
    in which Q is NHj or 1-methyl-2-methoxycarbonylvinylamine, R is hydrogen or hydroxyl; B - group of formula
    / °
    A / (.n-
    about
    X N UU. X .. I
    g T-CH;
    / -N-J
    0
    five
    five
    0
    five
    0
    where Xi is hydrogen (Ba), CH20H (Bb); (Ec} or their pharmaceutically acceptable alkali or quaternary ammonium salts with antibacterial activity ”
    The aim of the invention is to develop, on the basis of known methods, a method of producing new compounds possessing valuable pharmacological properties with low toxicity.
    C r i me r K A mixture of 17.0 g (0.0665 mol) sodium 1, 1-dioxopenicillanate, 18.0 g (0.0634 mol) benzyl chloromethyl adipate, 6.7 g (O5, 020 mol of tetrabutylammonium bromide and 300 ml of acetone are heated under nitrogen at reflux overnight. Acetone evaporated) T5 and the residue is placed in 300 ml of ethyl acetate. Water (150 ml) was added, the organic layer was separated, and the aqueous layers were extracted with fresh ethyl acetate (150 ml). The combined organic extracts are washed with water (3 X 250 ml) and brine (2 x X 150 mp), dried () and concentrated in vacuo to an oil (31.8 g). This oil is chromatographed on 700 g of silica gel, eluting with hexanes ethyl acetate 2s to remove less polar impurities, then ethyl acetate; hexane 1: 1 for the selection of the product. After evaporation of the solvent from the fractions, 27.3 g (89.5%) were obtained from the product.
    Using the corresponding methyl half ester or other alkyl half esters, where the alkyl is ethyl, n-propyl, isopropyl, n-butyl, or isobutyl, the corresponding alkyl-1,1-dioxopenicilloyloxymethyl dicarboxylate is obtained in a similar way instead of the benzip half-ester.
     Example 2. Monobenzyl ester of cis-1,2-cyclohexane-carboxylic acid.
    To 15.4 g (0.10 mol) of cis-1,2-cyclohexanedicarboxylic anhydride in 200 ml of toluene is added dropwise
    15
    For 30 minutes, the crystalline product was removed by filtration, washed with water and air dried to obtain 58.2 g of the indicated carbonic acid. After recrystallization, Kristaplica monohydrate is obtained from the ethels, mp. 00-102 C.
    Elemental analysis.
    Calculated,%: C 44.00; H 5.66;
    20 N 3.42,
    C, E,
    C 43.93; H 5.65;
    a solution of 10.8 g (o, 10 mol) of benzyl water. After stirring the alcohol in 50 MP of toluene. The resulting mixture is stirred at room temperature for 1 hour, then warmed to and kept at this temperature for 1 hour. The solvent is evaporated to a small volume and the target monoester is obtained after cooling and filtering the solid precipitate (t, mp 69-7l s),
    In another embodiment, the reaction mixture in toluene is treated with an equimolar amount of ethanolic potassium hydroxide to form the potassium salt of the monobenzyl ester. The sodium salt is obtained using methanol sodium hydroxide in the same manner.
    The corresponding monobenzyl esters or their sodium or potassium salts are obtained by the described method from the following di-anhydrides. carboxylic acids: succinic anhydride, glutaric anhydride (reflux overnight).
    Example 3. Crystalline hydrate of I, 1-dioxopenicol llyloxy-methyl adipic acid.
    To 400 ml of acetone was added 48.5 g (0.19 mol) of sodium-1,1-dioxopenicil. Found, (i.e., N, 3.42).
    The crystallinity of the product is pidzerz-25 dene by x-ray crystallography.
    Example 4. Sodium-1,1-dioxopenicillanoyl of Simeti-and-trans, 4-β -dichehexanedicarboxylate. 30 A Benzsthlormetl-trays-1,4-cyclohexane dicarboxylate.
    To a mixture of 3.06 g (0.036 mol) of sodium bicarbonate, 5.46-G (0.018 mol), potassium benzyl trans-1,4-diclohexanedi- gg carboxylate, 50 ml of water and 500 ml of chloroform were added 6.17 g ( 0.018 mol) of tetrabutylammonium acid sulfate. The mixture is stirred at room temperature in
    . lanata, 48.0 g (0.27 mol) of beesyl chlorome- up to overnight. Layers section pnut. Aqueous, tiladipate, 19.3 g (0.06 mol) of the tetrabuse are extracted twice with chloroform, tilammonium bromide. The resulting mixture, the combined chloroform layers, is dried, heated at the boil with refluxing and evaporated to dryness. The resulting salt was filtered overnight, filtered, the tetrabutylammonium was placed in methylene chloride, washed with acetone and the filtrate was evaporated with 45 chloride (20 ml) and this solution was added. The resulting residue is placed in 20 ml of bromochloromethane with 500 ml of ethyl acetate, washed alternately with brine and water (250 ml portions), again with brine, and dried over magnesium sulfate. After evaporating the solvent g in vacuo, 89.6 g of a light yellow oil are obtained. This oil is placed in 250 ml of ethyl acetate.
    OS The mixture is stirred
    20.0 g of 10% Pd / C are added and the mixture is hydrogenated at a pressure of 3.52 kg / cm for 1 hour. After adding 15 g of fresh catalyst, the hydrogenation is continued for 2.5 hours. The catalyst is removed by filtration 55
    at ambient temperature for 70 hours, the solvent is evaporated and ethyl acetate is added to the residue. The tetrabutylammonium bromide precipitated out is removed by filtration, the filtrate is dried () and evaporated in vacuo to give 5 g (91%) of the crude product. After purification by chromatography on silica gel, elution with ethyl ether 1: 3 mixture yields 1.9 g (35%) of the desired product as an oil.
    After washing, the cake was washed with acetone (1500 ml) and the combined filtrate and washes were evaporated in vacuo until 1 ml of a viscous oil. This oil is placed in 150 MP of acetone and water is slowly added to start crystallization, and then continue until all SCO ml is added.
    For 30 minutes, the crystalline product was removed by filtration, washed with water and air dried to obtain 58.2 g of the indicated carbonic acid. After recrystallization, Kristaplica monohydrate is obtained from the ethels, mp. 00-102 C.
    Elemental analysis.
    Calculated,%: C 44.00; H 5.66;
    N 3.42,
    water. After stirring for
    C, E,
    C 43.93; H 5.65;
    Found, / „, N 3.42.
    The crystallinity of the product is pidzerdna by x-ray crystallography.
    Example 4. Sodium-1,1-dioxopenicillanoyl of Simeti-and-trans, 4-β -dichehexanedicarboxylate. And Benzsthlormetl-trays-1,4-cyclohexane dicarboxylate.
    To a mixture of 3.06 g (0.036 mol) of sodium bicarbonate, 5.46-G (0.018 mol), potassium benzyl trans-1,4-diclohexanedi-carboxylate, 50 ml of water and 500 ml of chloroform were added 6.17 g (0.018 mol) tetrabutylammonium sulphate. The resulting mixture overnight flow. Layers section pnut. The aqueous layer was extracted twice with chloroform. The combined chloroform layers were dried and evaporated to dryness. The tetrabutylammonium salt is placed in methyl chloride (20 ml) and this solution is added to 20 ml of bromochloromethane at
    OS The mixture is stirred
    over night Layers section pnut. The aqueous layer is extracted twice with chloroform, the combined chloroform layers are dried and evaporated to dryness. The tetrabutylammonium salt is placed in methylene chloride (20 ml) and this solution is added to 20 ml of bromochloromethane at
    at ambient temperature for 70 hours, the solvent is evaporated and ethyl acetate is added to the residue. The tetrabutylammonium bromide precipitated out is removed by filtration, the filtrate is dried () and evaporated in vacuo to give 5 g (91%) of the crude product. After purification by chromatography on silica gel, elution with ethyl ether 1: 3 mixture yields 1.9 g (35%) of the desired product as an oil.
    1 H-NMR (CDCl.) ELm.dg 1.0-2.4 (m, lOlOl 5.1 (s, 2H); 5.7 (s, 2H); 7.3 (s, 5n),
    B. Benzyl-1,1-dioxopenicillan-shyuksimetil-trans, 4 cyclohexanedicarboxylate.
    A solution of 4.2 g (13.5 mmol) of benzyl chloromethyl trans-1,4-cyclohexanedicar bauxilate, 3.63 g (14.2 gmol.) Sodium, dioxopenicillanate 5 1545 g (4.5 mmol) and 100 ml The acetone is heated at reflux overnight. The acetone is evaporated, ethyl acetate (100 ml) is added, the solution is washed with water (three times), brine and dried over anhydrous sodium sulfate. The solvent is removed by evaporation in vacuo to yield an impure product, which is purified by chromatography on a column of silica gel, eluting with ethyl acetate 1: 1 to give 5.3 g (78%) of the purified product as an oil, which is used in the next stage,
    . C To a solution of 2j5 g (4.9 mmol) of the benzyl ester obtained in part B in 50 np of ethyl acetate under nitrogen atmosphere is added 1.5 g
    30 To a solution of 18.53 g (0.062 mol) of potassium benzyl terephthalate in 300 mp of water, add 600 ml of chloroform, 10.38 (0.121 mol) of sodium bicarbonate and 20.95 g (0.062 mol) of acid sul
    0% Pd / C catalyst. The resulting mixture is hydrogenated at a pressure of -2 atm for about 20 minutes. The catalyst was removed by filtration, and 0.82 g (4.9 mmol) gg tetrabutylammonium phate was added to the filtrate. The resulting sodium-2-ethylhexanoate. After the over-mixture is stirred at room temperature
    stirring for 30 minutes at room temperature, the crawled mixture is concentrated to one third of the volume
    temperature for 3 hours, the organic layer is precipitated, and the suitable phase is extracted twice with chloroform, Op
    and add three volumes of ethyl iphi-40, the layers are combined, dried
    The precipitated compound is filtered off, washed with ether and dried under nitrogen to give 1.7 g (79% yield of the step).
    Example 5 Crystal Ij-Dioxopenitol-lanoyl-oxymethyl-trans 194-cyclohexanecarboxylic acid.
    (Na. And the solvent is evaporated to obtain the tetrabutylammonium salt of benzyl terephthalate. It is placed in 25 ml of methylene chloride and the resulting 45 solution is added dropwise to 100 ml of bromochloromethane at the resulting mixture allowed to warm to room temperature, stirred overnight. And the product is isolated and clear
    To a solution of 6.07 g (12 mmol) of benzyl, 1-dioxopenicillanoyloxymethyl-gQ in Example 5 (part A) to obtain -trans-154-diclohexanedicarboxylate of the indicated diester in the form
    in 100 ml of ethyl acetate in the atmosphere of azo-crystals, t.-pl, 64-6b with,
    B. Benzyl-, 1-dioxopenicillanoyloxymethyl terphthalate.
    A solution of 6.34 g (0.021 mol) of benzyl chloromethyl terephthalate, 5.58 g (0.022 mol) of sodium, 1-dioxopenicillanate, 2.24 g (0.0069 mol) of tetta, was added 3.2 g of 10% of RBUS as a catalyst. The resulting mixture was hydrogenated for 45 minutes, shaken at 50 psi (3552 kg / cm -). The mixture is filtered, the filtrate is concentrated in vacuo to give an oil in the residue, which crystallizes on standing.
    55
    rabutilammonium bromide and 200 ml aceto
    057046
    This product is recrystallized from a mixture of ethyl agate and hexane under a nitrogen atmosphere to yield 2.35 g
    g of a crystalline product that contains some amount of oil. It is placed in ethyl acetate (100 mp) and an equivalent amount of sodium 2-ethylhexanoate is added.
    10 precipitate the sodium salt is stirred for 45 minutes, concentrated to one third of the volume and add ethyl ether to complete the precipitation. The sodium salt is collected by filtration.
    15 ml, washed with ether and dried under a nitrogen atmosphere, then placed in water (50 ml), acidified with hydrochloric acid and the resulting mixture extracted with ethyl acetate. The extracts are dried (),
    20, the solvent is evaporated in vacuo, the residue is crystallized from a mixture of ethyl acetate and hexane and dried in a nitrogen atmosphere to obtain 1.85 g (37%) of crystalline product, t, mp.
    25 118.5-119 ° С,
    Example 6, 1,1-dioxopen-β-chillanoyloxymethyl terephthalate and its sodium salt,
    A, Benzylchloromethyl terephthalate,
    30 To a solution of 18.53 g (0.062 mol) of potassium benzyl terephthalate in 300 mp of water, add 600 ml of chloroform, 10.38 g (0.121 mol) of sodium bicarbonate and 20.95 g (0.062 mol) of acid salt.
    ) gg tetrabutylammonium veil. The mixture is stirred at room temperature.
    temperature for 3 hours, the organic layer is precipitated, and the suitable phase is extracted twice with chloroform, Or-,
    (Na. And the solvent is evaporated until the benzyl terephthalate tetrabutylammonium salt is obtained. It is placed in 25 ml of methylene chloride and the resulting solution is added dropwise to 100 ml of bromochloromethane at. The mixture is allowed to warm to room temperature, stirred overnight. And the product is isolated and clear
    in Example 5 (Part A) to obtain the specified diester in the form
    rabutilammonium bromide and 200 ml aceto
    stir under refluxing under nitrogen for 18 hours. Then the acetone is evaporated, the residue is taken up in ethyl acetate, washed with water three times and dried (). After evaporation of the solvent, 1I g of crude product is obtained, which is purified by passing through a column of silica gel (20x2 cm), eluting with a mixture of ethyl acetate: hexane 1: 1. After evaporation of the obtained fractions, 10 g (96%) of the desired benzyl ester are obtained as an oil.
    C. A solution of 9 g of benzyl ester obtained in part B in 50 MP of ethyl acetate is pumped out to remove air and the vessel is filled with nitrogen. 2.5 g of 10% Pd / C catalyst are added to the solution and the mixture is hydrogenated at a pressure of 3 atm in for 20 minutes The mixture was filtered through a filter, washed with ethyl acetate, 2.98 g of sodium 2-ethylhexanoate was added to the filtrate, and the mixture was stirred for 30 minutes. Additionally by
    50 ml of ethyl acetate and ethyl acetate are added to the resulting thick mixture, which is filtered and washed with ethyl ether. After the dog overnight, 5.8 g (75%) of crystalline sodium salt are obtained.
    D. To a solution of 1 g of capped sodium salt in 50 MP of water, 50 ml of 0.1N hydrochloric acid is added. The resulting mixture is extracted with 75 mp ethyl acetate. Ethyl acetate is concentrated in vacuo to form a suspension and enough ethyl acetate is added to dissolve the precipitate. The solution is stirred while slowly adding hexane at room temperature to a cloud point. The solution is then heated on a steam bath to improve dissolution, and a few drops of hexane are added, the mixture is cooled to room temperature.
    and placed in the fridge. The resulting crystals are collected by filtration and dried under a nitrogen atmosphere to obtain 900 mg (95%) of the indicated acid, t, mp 167-169 ° C (with decomposition).
    Example 7. Sodium-1,1-dioxoppenitzshanoyloxymethyl isophthalate.
    A. Benzyl chloromethyl isophthalate.
    According to example 7 (part A), 17.0 g (0.058 mol) of potassium benzenshzophthalate in
    45 ml of water and 500 ml of chloroform; It is grown in its tetrabutylammonium salt and reacted with an excess of bromochloromethane. The crude product obtained (15 g) is taken up in ethyl acetate and added to 45 g. silica gel, “the mixture is suspended and the solvent is evaporated. The remaining clikel in a dry state is loaded into an 8-inch column with silica gel and eluted with ethyl ether 1: 3 mixture. After evaporation of the solvent from the fraction containing the product, the desired D1-1 ester is obtained in the form of an oil,
    B, Benzyl-, i-dioxopenicillano-iloximethi.tkz oftalat.
    A mixture of 12.22 g (0.04 mol) of benzyl chloromethyl isophthalate, 10.75 g
    (mol) benzyl chloromethyl isophthalate, 10.75 g (0.042 mol) sodium-1S i-dis.exopencillanate, 4, 31 g (0.0134 mol) of tetrabutylamine mochibromide and 400 ml of aiteTOKa are heated at
    under reflux c. for 30 hours. Acetone is evaporated and replaced with ethyl acetate. Rinse solution; -. watered three times with water, brine and dried
    (Na.SO), Po1: after evaporation of the solvent and chromatography of the residue on silica gel, eluting with ethyl acetate: hexane 65: 35, the product is obtained in the form of an oil, which crystallizes at 41%, yield 41%,
    C, A mixture of 8.14 g (0.016 mol) of the benzyl ester obtained
    in part B, 2.5 g of 10% Pd / C catalyst and 50 ml of ethyl acetate are hydrogenated
    as described in Example 7 (Part C). The mixture was filtered to remove the catalyst and 2.7 g (0.016 mol) of sodium 2-ethylhexanoate was added. After stirring for 20 minutes, viscous
    the slurry is concentrated to one third of the volume and ethyl ether is added to complete the precipitation. The crystals obtained are filtered and dried under a nitrogen atmosphere to give 6.35 g
    (90%) of the specified sodium salt.
    Example 8. 6-tD- (2-amino-2-phenylacetamido) penicillanoyl oximethyl trans-1,4-cyclohexanedicarboxylic acid, hydrochloride.
    55
    A. Benzyl-6- {1) (1-methyl-2-methylcarbonylvinylamino) -2-phenylacetamido} penicillanoyloxymethyl-trans-1,4-cyclohexanedicarboxylate.
    A solution of 2.22 g (3.28 mmol) of tetra-b utilum ammonium-6 D- 2- (1-methyl-2-methoxycarbonylvinylamino) -2-phenylacetate aMHfloJj penicillanate, 1.0 g (3.23 mmol) benzyl chloromethyl trans-1,4-cyclohexane dicarboxylate and 100 ml of acetone are stirred at room temperature overnight. The acetone is evaporated and replaced with ethyl acetate. The solution is washed with water, dried (NanSOx) and the solvent is evaporated in vacuo. The remaining crude material is purified by chromatography on silica gel, eluting with ethyl acetate-hexane 40; 60 to give 1.5 g (53%),
    B. The benzyl ester obtained in Part A, 5 g (2.08 mmol) is dissolved in 25 ml of acetone and 20.1 ml of 0.1 N hydrochloric acid is added. The mixture is stirred for 10 minutes. an additional 2.0 ml of 0.1 N hydrochloric acid is added and the solvent is evaporated, 75 ml of water are added to the residue, the mixture is extracted twice with ethyl ether containing a small amount of ethyl acetate, 0.75 g is added to the extracts obtained 10% Pd / C catalyst J and the resulting mixture was shaken under a hydrogen pressure of 50 psi (3–52 kg / cm) for 30 minutes. The catalyst was removed by filtration, and the resulting filtrate was freeze dried to obtain 700 mg of product.
    Example 9, 6-B-2-aivMHO- - (4-hydroxyphenyl) acetamido penicillano yloxymethyl trans-1,4-cyclohexanedibarboxylic acid, hydrochloride,
    A, Benzyl-6- (G) (1-methyl-2-metoxycarbonylvinnla, but) -2- (4-hydroxyphenyl) acetamido j penicillanyloxy-methyl-trans-1,4-cyclohexanedicarbic silate.
    A solution of 0.5 g (1-561 mmol) of benzyl chloromethyl-trans-1,4-cyclohexanedicar bauxilate and 1.14 g (ls61 mmol) of tetrabutylammonium-bG (1-methyl-2- methoxycarbonylvinylamino) -2 (4-hydroxyphenyl) acetamide penicillanate in 50 ml of dimethylformamide is stirred overnight at room temperature. The reaction mixture was diluted with ethyl acetate, washed three times with water, then with brine, and dried (NajSO4). The solvent was evaporated in vacuo. Ethyl acetate is added to the residue, and the mixture is washed again.

    0
    five
    water, brine, dried and evaporated to remove residual dimethylformamide. The residue is purified on silica gel by chromatography, eluting with ethyl acetate: hexane 7: 3 to obtain 500 mg (42%) of a purified diester,
    B. To a solution of 0.5 g (0.678 mmol) of the purified diester obtained in Part A in 25 ml of acetone was added 6.8 ml of 0.1 N hydrochloric acid. After stirring for 10 minutes, an additional 1.0 ml of 0.1 N hydrochloric acid was added and the acetone was evaporated in vacuo. The residue was partitioned between water and ethyl ether, and the aqueous layer was washed with ether. 0.35 g of a 10% Pd / C catalyst was added to the aqueous phase under a nitrogen atmosphere, and the mixture was hydrogenated at 50 psi (3.52 kg / cm) overnight. The mixture was filtered to remove the catalyst, and the aqueous filtrate was freeze dried to obtain 200 mg (50%) of the title compound.
    Example 10, Sodium-6- (2-phenoxy acetamido) penicyl-panoyloxymethyl-dimethylmalonate,
    0AO Benzyl-6 (2-phenoxyacetamido)
    penicillanoyloxymethyl dimethylmalonate - To 50 ml of dimethylformamide, 3.88 g (0.01 mol) of potassium-6- (2-phenoxy-acetamido) penicillanate, 2.7 g of g (mol) benzyl chloromethyl dimethyl malonate are added. The resulting mixture was stirred at room temperature for 3 hours. The mixture was poured into 150 ml of ethyl acetate, washed with water (3 x 0 x 50 mp), brine (1 x 50 ml), dried () and evaporated to dryness in vacuo. The residue is placed in a small amount of ethyl acetate and transferred to a silica gel column (200 g), the column is eluted with ethyl acetate: hexane 1: 1, the resulting product fractions are combined and concentrated in vacuo to obtain 2.0 g of product in as colorless oil.
    In a mixture of 2.0 g (3.4 mmol) of the product from part A, 40 mp of ethyl acetate and 2.0 g of 10% Pd / C catalyst are stirred under a hydrogen atmosphere at a pressure of 50 psi for 45 hours. Another 1 g of catalyst is added and stirring is continued for 30 minutes. The half-shn mixture is filtered, and the filter cake is washed with ethyl acetate. Filtrate and washing, mix, do0
    55
    Bavl 0.56 g (3.37 mmol) sodium 2-ethylhexanoate. Stirring is continued by adding an equal volume of ethyl ether. The precipitated solid is granulated by stirring for 30 minutes, filtered, washed with ether and dried under a nitrogen atmosphere to obtain 1.35 g (77%) of the indicated salt.
    Example P. Sodium-6- (2-Fe-Q Noxiacetamido) Penicillanoyloxymethyl Glutarate.
    A, Benzyl-6- (2-phenoxyacetamido) penicillanoyloxymethylglutarate,
    To 50 ml of dimethylformamide, 15 salts are added and precipitated with ethyl ether, and 3.88 g (0.01 mol) of potassium-6- (2-phenoxyl) are filtered by filtration to obtain siacetamido penicillanate, 2.7 g 1,, 95 g (63% of the indicated compound, (0.01 mol) of benzylchloromethylglutarate. Example 13, Repeat method. The resulting mixture is stirred in Example 12 with sodium 6- (2,6-dimethoxy-; for 3 h, then added 3.0 g 20 benzyl (Ido) penicillanate and benzyl chlorine
    purified according to example 11 to obtain benzyl-6- (2,6-dimethoxybenzamido) penicillanoyloxymethyl dimethylmalonate in 65% yield,
    To 3.5 g (5.7 mmol) of this benzyl ester in 50 ml of ethyl acetate was added 2.5 g of a 10% Pd / C catalyst. The resulting mixture is hydrogenated at a pressure of 50 psi for 1 hour. After filtration, to remove the catalyst, an equimolar amount of sodium-2-ethylhexanoate in ethyl acetate is added to the filtrate.
    (0.02 mol) sodium iodide. Stirring is continued overnight. The reaction is quenched by adding 150 ml of ethyl acetate. Wash the reaction mixture with water (3 × 50 ml), brine (1 × 50 ml) and dry with Na SO. After evaporation of the solvent in vacuo, 6.0 g of oil is obtained, which is purified on chromatomethyl glutarate on a 2.2 molar scale to give benzyl 6- (2,6-dimethoxybenzamido) penicillaclacoyl symethyl glutarate in a 25% yield as an oil.
    Hydrogenation of 1.4 g (2.2 mmol) of the described benzyl ester-. Pa on a Pd / C catalyst according to the method used in g.reddiz cich is used in the form of 30 paxj and the conversion of sodium 2-ethylhexanoate to sodium salt results in a yield of 0.87 g (72.5%) sodium sd-6-. - (2,6-dimethoxybenzamido) penioillic iioxymethylglutarate.
    a graphical column on silica gel (300 g), eluting with ethadeladate: hexane 1: 1. After concentrating the fractions containing the product, 5.0 g (85%) of a colorless oil is obtained.
    B. The product obtained in Part A, 5.0 g (0.0085 mol), 50 ml of ethyl acetate and 35 g, and 5 g of 10% Pd / C catalyst are hydrogenated at a pressure of 3 atm for 1 hour. An additional 2 are added. 5 g of the catalyst and hydrogenation are continued for another 2 h. The mixture obtained is filtered through a diatomaceous Zempu, washed with ethyl acetate. The combined filtrate and washings with 200 ml were poured into a clean flask and 6.13 ml of sodium-2-ethylhexanoate in ethyl acetate (0.23 g / ml) was added. After stirring for 30 minutes, the resulting mixture was diluted with an equal volume of ethyl ether and filtered to obtain 2.25 g (51%) of the sodium salt.
    Example 12. Sodium-6- (2,6-dimethoxybenzamido) penicillanoyl oximethyldimethylmalonate.
    A mixture of 4.02 g (0.01 mol) sodium. Hydrogenation of 1.4 g (2.2 mmol) of the described benzyl ester. Pa on a Pd / C catalyst according to the method used in g.reddiz cich is used in the form of 30 paxj and the conversion of sodium 2-ethylhexanoate to sodium salt results in a yield of 0.87 g (72.5%) sodium sd-6-. - (2,6-dimethoxybenzamido) penioillic iioxymethylglutarate.
    Example 14, 1,1-Dioxopenicillonoyloxymethyl-6-D-2- (1-methyl-2-methoxycarbosh-1-vinylamino) -2-phenylacetamido penicillanoyl-oxymethyl-trans-1,4-cyclohexanediocarboxylate. A mixture of 2.33 g of i3.97 mmol) sodium -1,1-dioxopenicillanoyl oxymethyl-trans-1,4-cyclohexanedicarboxylate, 1.72 g (3.97 mmol) iodomethyl-6-D- 2- (1-methyl -2-methoxycarbonylvinyl-45 amino) -2-phenylacetamido penicillatate and 40 ml of dimethylformamide are stirred at room temperature for 1 hour. 5 min. The mixture is diluted with ethyl acetate, washed three times with small portions of water, once with brine and. dried (). After evaporation of the solvent in vacuo and chromatography of the residue on a column of silica gel, eluting with ethyl acetate 50
    -6- (2,6-dimethoxybenzamido) penicilla-55t and hexane get 1.4 g (40%) of the pentate, 3.3 g (0.01 mol) of benzyl chloro-enamine.
    methyl dimethyl malonate and 30 ml of dimethyl Example 15. 1,1-Dioxane penenformamide is stirred at 25 ° C in tecillianoyloxymethyl 6-1- (2-amino-2-hour for 60 h, then the product is isolated and phenylacetamido) penicillanoyl oxycleaned as in Example 11 to obtain benzyl-6- (2,6-dimethoxybenzamido) penicillanoyl oxymethyl dimethyl malonate in 65% yield,
    To 3.5 g (5.7 mmol) of this benzyl ester in 50 ml of ethyl acetate was added 2.5 g of a 10% Pd / C catalyst. The resulting mixture is hydrogenated at a pressure of 50 psi for 1 hour. After filtration, to remove the catalyst, an equimolar amount of sodium-2-ethylhexanoate in ethyl acetate is added to the filtrate.

    methylglutarate on a 2.2 molar scale to obtain benzyl-6- (2,6-dimethoxybenzamido) penicillacoyloque simethylglutarate in quantitative yield as an oil.
    Hydrogenation of 1.4 g (2.2 mmol) of the described benzyl ester on a Pd / C catalyst according to the method used in the town of Przyc and used to convert the sodium-2-ethylhexanoate to sodium salt results in 0 , 87 g (72.5%) of natrny-6- - (2,6-dimethoxybenzamido) peiniylgioxyoxymethylglutarate.
    Example 14, 1,1-Dioxopenicillonoyloxymethyl-6-D-2- (1-methyl-2-methoxycarbosh-1-vinylamino) -2-phenylacetamido penicillanoyl-oxymethyl-trans-1,4-cyclohexanediocarboxylate. A mixture of 2.33 g of i3.97 mmol) sodium -1,1-dioxopenicillanoyl oxymethyl-trans-1,4-cyclohexanedicarboxylate, 1.72 g (3.97 mmol) iodomethyl-6-D- 2- (1-methyl -2-methoxycarbonylvinyl-amino) -2-phenylacetamido penicillatate and 40 ml of dimethylformamide are stirred at room temperature for 1 hour. 5 min. The mixture is diluted with ethyl acetate, washed three times with small portions of water, once with brine and. dried (). After evaporation of the solvent in vacuo and chromatography of the residue on a column of silica gel with elution with ethyl acetate
    m and hexane get 1.4 g (40%) of the pure enamine.
    methyl trans-1,4-cyclohexanedicarboxy silate, hydrochloride.
    . To a solution of 1.4 g (1.61 mmol) of 1,1-dioxopenicillanoyloxymethyl 6- (1-methyl-2-methoxycarbonylvinylamino) -2-phenylacetamido penicyllyanoyl-oxymethyl trans-1,4-cyclohexanedibarboxylate. In 150 ml of acetone are added with 20 ml of 0.1 hydrochloric acid. The solution is stirred for 5 minutes. The solvent is evaporated in vacuo, the residue is diluted with water, the aqueous phase is washed twice with a mixture of ethyl ether: ethyl acetate; 1, The aqueous phase is filtered and dried by freezing to obtain 634 mg (48%) of the indicated compound, t, mp, 155-170, С (. With decomposition)
    Example 16, Benzyl chloromethyl sebacate, To a mixture of 48.67 g (o, 155 mol) of monobenzyl sebacate, g (0.301 mol) of bicarbonate, sodium, 200 ml of water and 52.55 g (0.155 mol) of tetrabutylammonium hydrogen sulfate are added 100 ml chloroform. After shaking, the organic layer is separated, the aqueous phase is extracted again with chloroform and the combined chloroform layers are dried. (After evaporation of the solvent, the residue is placed in 50 m bromochloromethane and stirred overnight at room temperature. The mixture is evaporated in vacuum, the residue is mixed with ethyl acetate, filtered, and the filtrate was concentrated in vacuo. The remaining product was purified on a silica gel chromatography column to obtain 2 g of purified mono ™ ester as an oil.
    Example 17 in 1.1 Dioxopenicillanoyl-oxymethyl-6- | D 2- (1-methyl-2-methoxycarbonyl-vinylamino) -2-phenylacetamido penicillanoyloxymethyl sebacinato
    To a solution of 0.59 g (mmol) iodomethyl-6-1-2- (1-methyl-2 methoxy carbonylvinylamino) -2-feiyl acetamido penicillanate in 10 ml of dimethyl forms and 0.47 g (1.0 mgdal) of sodium 1, 1 D4 oxopenicil; anhydroxymethyl 1-sebacate, the mixture obtained is stirred until solution is obtained. The reaction mixture was subjected to instant chromatography on a column of silica gel, 23 cm thick, eluting with ethyl acetate, Hax 7: 3 to obtain 200 mg (22%) of the desired enamine.
    5 0 o
    g
    g
    five
    Example 18, 1, -dioxopenicillanoyloxymethyl-6-1) - (2-amino-2-phenylacetamido) penicillanoyloxymethyl sebacate, hydrochloride.
    To a stirred solution of 200 mg (0.22 mmol) penicillanoyloxymethyl- (1-methyl-2-methoxycarbonyl-vinylamino) -2-phenylacetamido penicillanoyl-oxymethyl sebacate in 25 ml of acetone is added 3.2 ml of O, 1.n, hydrochloric acid The resulting mixture was stirred for several minutes, another 1.0 MP of hydrochloric acid was added and stirring was continued for another 1 minute. The acetone is evaporated, the residue is diluted with water and washed twice with a mixture of ethyl ether and ethyl acetate. The aqueous layer was filtered and freeze dried to obtain 110 mg (59%) of product.
    Example 19, I, l-dioxapenyl-cyclomethyl-6-D- (2-amino-2-phenylacetamido) j penicillanoyloxymethylterephthalate, hydrochloride.
    A.1,} - Dioxypenicillanoyl-oxo-methyl-6-D- 2- (1-methyl-2-methoxycarbonylvinylamino) -2-phenylacetamido pera-1-shch1lloroyloxymethyl terephthalate.
    To a solution of 0.59 g (1 mmol) iodo-methyl-6- - 2- (1-methyl-2-methoxy-carbonylvinylamino) -2-phenylacetamide} penicillanate in 10 ml of dimethylformamide, 0.48 g (1 , 1 mmol) sodium-1,1-dioxopenicillanoyl oxymethyl terephthalate. The resulting mixture is stirred until a solution is prepared, which is diluted with ethyl acetate and washed with small portions of water (three times), once with brine and dried (). The solvent is evaporated in a vacuum, and the residue is placed in a small amount of ethyl acetate and purified on a chromatographic silica gel column. by eluting with ethyl acetate: hexane 614. fractions containing products, evaporated to obtain an enamine-substituted compound 0.3 g (23%),
    B, To the stirred solution
     g (o, 35 mmol) of the described enamine-protected product in 25 ml of acetone is added 4.5 mp of 0.1 N hydrochloric acid. The mixture was stirred for several minutes, the solvent was evaporated, and the residue was partitioned between water and ethyl ether. Then the aqueous phase is washed with ethyl zfir; 1: 1 ethyl acetate, filtered, and the resulting filtrate is freeze-dried.
    151405704 6
    To obtain 222 mg (78%), penicillicillanoyloxymethyl glutarate, hydrochloric acid salt, hydrochloride.
    Example 20, 1,1-Dioxopeni - Analogously to 2.94 g (5 mmol) of that cyllanoyloxymethyl-6-1) - (2-amino-2-same-i-phenylacetamido-2-iodomethyl ester) penicillanoyl-oxytylacetoacetate-aminomethyl protected methyl acetate phthalate, hydrochloride , picillin, and 3.0 g (7.5 mmol) of sodium A, 1,1-dioxopenicillanoyloxymeryl-1,1-dioxopenicillanoyloxymethyl-6-1-C2- (1-methyl-2-methoxycarblutaric acid is stirred in 20 ml of dimethylvinylamino) -2-phenylacetamido} 1 ppm of tilformamide for 5 min and hanicillanoyloxymethyl isophthalate, with 150 ml of ethyl acetate being reacted. Half
    To a solution of 0.59 g (110 mmol), the iodized mixture is washed with water (3 x methyl-b-GG) (1-methyl-2-methoxy-carc x 50 ml), brine (50 ml), dried bonilvinylamino) -2 -phenylacetamido Jne- () and evaporated to dryness in vacuo-vacanate in 10 ml of dimethylformamide js Ume, The residue is purified on a chromatographic method, 0.43 g (1.0 mmol) is added to a sodium column with silica gel -1,1-dioxopenicone-xyloxymethyl - (100 g), eluting with a mixture of methylene chlorofthalate, The resulting learned mixture. Mixing mixture 60:40 (v / v) ethyl acetate (by volume), is added at room temperature until sampling every 60 s. Fractions of the dissolving scale. The reaction 20 16-24 is combined and the solvent is treated as described in example 19 and evaporated in vacuo to obtain 1.8 g (part A) to obtain 200 mg (23%) of foam. It is dissolved in 30 ml of acetone, the combined enamine, 21.5 ml of 0.1 N hydrochloric acid is added, the acid B, the enamine-protecting group is removed, and the mixture is stirred to obtain the hydrochloride as in Example 19-25 for 20 minutes. Acetone is evaporated (part c) in 94% yield, under reduced pressure, the aqueous phase
    Example 21, (2-Amino-, extract with ethyl ether (30 ml) -2-phenylacetamido) penicillanoyloxy- and a mixture of ethyl acetate: methyl 1-ethyl, dioxopenyl 1-methyloxy-1: 1 ethyl ether, The aqueous layer is filtered through dithylsucidate, hydrochloride, 30 atomic earth and obtained filtrate
    To a solution of 5.9 g (0.01 mol), iodo lyophilize to obtain 1.45 g of methyl 6-1) (1-methyl-2-methoxycar- (37%) of the target hydrochloride, bonylvinylamino) -2-phenylacetamido 5 According to the described method, penicillanate is obtained in 30 ml of dimethylforma- the other compounds, and 5.5 g (0.014 mmol) of sodium B g (2-amino-2-phenylacetamium-1,1-dioxopenylshanoyloxymethyl) are added. J penicillanoyloxymethyl-1,1-dioxy succinate with stirring. After copenicillanoyl oxymethyl adipate, 150 ml of ethyl acetate, rochloride are added over a 20 minute period.
    The resulting mixture was washed with water C, (2-Amino-2-phenylacetam- (3x50 ml), brine (50 ml). Water 40 to)} penicillanoyl-oxymethyl-1,1-diox- (2x50 mp), brine (50 ml), coenicillanoyloxymethyldimethyl-malo- (Na, jS04) is dried and concentrated to 6.3 g of gelatin, hydrochloride,
    of the foam. The resulting product is dissolved in D. (2-Amino-2-phenylacetamide in 60 ml of acetone and hydrolyzed. until) penicillanoyl oxymethyl-1,1-dioxane with stirring from 80 ml. coenicillanoyloxymethylmalonate, hydrochloric acid for 15 minutes, acetochloride,
    the tone is removed in vacuo and the aqueous residue is extracted. Example 22, (2-Amino-2-current is extracted with ethyl acetate 50 ml) with 1, -phenylacetamido) penicillanoyl oxime - ethyl acetate: ethyl-tylo-1,1-dioxopenicillanoyl-oxymethyl-1: 1.75 ml and again with ethyl acetate 50 glutarate, hydrochloride, (50 ml). The aqueous phase is filtered to A, 6- (1) - (2-Azido-2-phenylacetamite, to obtain a clear solution, to) penicillanoyl oxymethyl-1,1-dioxid after freeze-drying with da-coenicillanoyl oxymethylglutarate, em 2.95 g solid mixture. After chromate-to a mixture of 1.18 g (0.0023 mol) on Sephadex LH-20 55 methyl-6-E1- (2-azido-2-phenyenetatami- (water) iodization, 0.26 g (3%) are obtained. pure do) penicillanate and 1.2 g (0.003 mol) of hydrochloride, sodium-1,1-dioxopenicillanoyl oxime-,
    A, 6- {D- (2-Amino-2-phenylacetamyl-tolumate) was added 15 ml of dimethyl-) penicillanoyloxymethyl-1,1-dioxformamide. The resulting mixture is stirred until a solution is obtained. After 1 hour, another 1.0 g of sodium salt was added, and the resulting solution was stirred for another 30 minutes, diluted with ethyl acetate (100 ml), washed with brine (2 x 30 ml), water (2 x 30 ml), brine (1 x 30 ml) , dried (NajSOA) and concentrated in vacuo to a foam. After chromatography on a column of silica gel (100 g) and elution with a mixture of ethyl acetate: hexane 7: 3, 0.72 g (43%) of the purified azido compound is obtained.
    at. The resulting 1 to 10 azide is dissolved in 15 ml of dx chloromethane and 3 to 5 ml of isopropanol and combined with 0.5 g of 0% Pd / C catalyst o. The resultant is hydrogenated under 50 psi (3.52 xg / cm) hydrogen for 45 min. After the addition of 0.25 g of catalyst, the hydrogenation is continued for another 30 minutes. The catalyst is removed by filtration, washed with a mixture of dihpormethane and isopropanol
    and the resulting filtrate is concentrated on 25 chloromethyl-i, 1-di oxopenicillanoyl vacuum in 3 ml of suspension. After adding 30 ml of diethyl ether, a precipitate is formed which, after stirring for 5 minutes, is filtered to obtain 0.24 g (35%) of the free base. A portion of the residue of 0.21 g is dissolved in 2.8 ml of Ojl ns hydrochloric acid and freeze dried after filtration through diatomaceous earth to obtain 0.14 g of hydrochloride.
    Example 23, (2-AMINO-2-phenylacetamido) J Penicillanoyl-oxymethyl-1,1-dnoxopenicillanoyl-oxymethyl adipate, hydrochloride.
    A. Using sodium-1,1-dioxopeniteneshloxyloximecladipate instead of sodium -, - dioxopenicillanoyloxymethylglutarate. Example 4 (part A)
    simethyl glutarate in. 2 ml of acetone was added 0.323 g (0.0005 mol) of tetrabutylamino-6- {1-2 (1 methyl -2 - metoxycarbonne-pinwino-amino) 2-phenyl-ace:
    30 amido pecicillanate with stirring. After peremegaivanie for 20 h at room temperature rast. the solvent is removed in vacuo and the residue is chromatographed on
     25 silica gel column, 7: 3 ethyl acetate: hexane mixture elun, to obtain 0.18 g of oil. To a solution of the obtained oil in 55 ml of acetone, add 2 ml of 0.1 N hydrochloric acid.
    40 and then an additional 5 ml of water. The resulting mixture (pH 1.2) is stirred for 30 minutes. The acetone is removed in vacuo, and the aqueous residue is washed with ethyl ether (2 x 30 ml) 5 is filtered and extinction 50
    obtain) (2.-azido-2-phenylacetate g is dried with gastric acid to obtain 0.12 g of amido) penitshshanoyloxymethyl 1,1-di (75% based on enamine) hydrochloropenophencyllanoyloxymethyl adipate with a yield of 37.7%.
    Example 24.. Chloromethyl-, I- -dioxopenicillanoyl-oxymethylglutarate.
    A solution of 3.9 g (0.0084 mol) of benzyl-1, 1-dioxopenicillanoyloximets-glutarate in 50 ml of tetrahydrofuran (THF) is hydrogenated in the presence of 3.0 g of gg of dimethylmaponate in 25 ml of water by adding 10% Pd / C The catalyst under pressure is 150 ml of chloroform, and then 8.5 g of 50 psi (3.52 kg / cm) of hydrogen in the app- (0.025 mol) of acidic sulphate of the Paar tetrarate of hydrogenation, Catalyst of butylammonium. The pH of the aqueous layer was adjusted by filtration, removed by filtering to 7.5 with stirring, before the mixture was added.
    Example 26. Iodomethyl-1,1-β-dioxopericellanoyloxymethyl dimethyl malonate,
    A. Chloromethyl-1,1-dioxopenicillioyloxymethyl dimethylmalonate.
    To a solution of 10 g (0.025 mol) of sodium-J1-dioxopenicillanoyloxymethyl is washed with THF and the filtrates are concentrated in vacuo to 3.5 g of a viscous oil. This oil is dissolved in 25 ml of chloroform, 10 ml of water are added. The resulting mixture is stirred and adjusted to pH 8.0 by the addition of 40% tetrabutylammonium hydroxide. The chloroform layer is separated and the aqueous layer is extracted with T-chloroform (2 x X 30 ml). The combined chloroform layers are dried () and concentrated in vacuo to obtain 5.8 g of the mixture, which is dissolved in 33 ml of iodo chloro-methane and stirred for 15 hours. After concentration in vacuo to chromatographic chromatography (mixture of ethyl acetate and hexane) 0.20 g (b%) of the title compound is obtained.
    Example 25. (2-Amino-2-- -phenylacetamco} penitshsanyoyloxymethyl- i, dioxopenicilloyloxymeth-glutarate, hydrochloride.
    To a solution of 0.2 g (0.0005 mol)
    simethyl glutarate in. 2 ml of acetone was added 0.323 g (0.0005 mol) of tetrabutylamino-6- {1-2 (1 methyl -2 - metoxycarbonne-pinwino-amino) 2-phenyl-ace:
    amido pecicillanate with stirring. After stirring for 20 hours at room temperature, the solvent is removed in vacuo, and the resulting residue is chromatographed.
    silica gel column, 7: 3 ethyl acetate: hexane elur to obtain 0.18 g of oil. To a solution of the obtained oil in 55 ml of acetone was added 2 ml of 0.1 N hydrochloric acid.
    and then an additional 5 ml of water. The resulting mixture (pH 1.2) is stirred for 30 minutes. The acetone is removed in vacuo, and the aqueous residue is washed with ethyl ether (2 x 30 ml) 5 is filtered and freeze dried to obtain 0.12 g (75% based on enamine) with hydrochloride.
    with live povakia dried to obtain 0.12 g (75% per enamine) hydrochloride
    dimethyl maponate in 25 ml of water was added with 150 ml of chloroform, and then 8.5 g (0.025 mol) of tetrabutylammonium acid sulfate. The pH of the aqueous layer was adjusted with stirring to 7.5, before the injection.
    Example 26. Iodomethyl-1,1-β-dioxopericellanoyloxymethyl dimethyl malonate,
    A. Chloromethyl-1,1-dioxopenicillioyloxymethyl dimethylmalonate.
    To a solution of 10 g (0.025 mol) sodium-J1-dioxopenicillanoyloxymethyl-sodium bicarbonate, the chloroform layer is added and the aqueous phase is extracted with chloroform (1 x 100 ml). The combined chloroform layers are dried () and concentrated in vacuo to obtain a viscous oil still containing chloroform. This oil is diluted with 95 ml of chloroiodomethane and stirred overnight. After concentration in vacuo and chromatography on 300 g of silica gel, eluting with ethyl acetate: hexane 1: 1 (v / v) 5, 7.4 g (70%) of the chloromethyl ester are obtained as an oil,
    B, To a solution of 7.4 g (0.0156 mol) of chloromethyl-1,1-dioxopenicillanoyl-s-methyl dimethylmalonate in 50 ml of acetone was added 11.75 g (0.78 mol) of sodium iodide. The resulting solution was stirred for 20 h. After concentration in vacuo, an oily solid is obtained, which is divided between 50 ml of water and JOO ml of ethyl acetate. The aqueous layer is extracted, the organic layer is washed with water (50 ml), brine (50 ml), dried (Na 2 SO 4) and concentrated in vacuo to a yellow oil. As a result of chromatography on silica gel (150 g), eluting with ethyl acetate: hexane 1: 1 (according to emu) gave 8.3 g (100%) iodometilovogo ester as a clear viscous oil.
    Example 27. 6- {g - 2-Amino- -2- (para-hydroxyphenyl) acetamido penicillanoyl oxymethyl, 1-dioxopenicol lanoyl oxymethyl dimethylmalonate, hydrochloride,
    A, (1-Methyl-2-methoxycar bonnvinylamino) -2- (p-hydroxyphenyl) acetamido penicillanoyloxy--1,1-dioxopenicillanoylmethyldimethylmalonate.
    To a mixture of 1.83 g (0.0026 mol) of tetrabutylammonium-6-1) (1-methyl-2-methoxycarbonylvinylamino) -2- (para-oxiphenyl) acetamido I penicillanate. And 1.35 g ( 0.0026 mol of iodomethyl-i, 1-.-Dioxopenicillanoyloxymethyl dimethyl malonate is added 10 ml of dimethylformamide. After moving for 15 minutes, the solution was diluted with 100 ml of ethyl acetate, washed with brine (25 ml), water (3x25 ml), brine (25 mp), dried () and concentrated to a foam. This foam is placed in ethyl acetate and chromatographed on


    100 g of silica gel, eluting with ethyl acetate: hexane 1: 1 (v / v), to obtain 1.2 g (54%) of an enamine-protected adduct,
    B, To the opioid enamine (1.2 g), dissolved in 30 ml of acetone, 14 MP 0.1 N. hydrochloric acid is added, after 20 minutes the acetone is removed in vacuo and the WATER residue is extracted with ethyl ether (2 x 50 ml) and ethyl acetate (30 ml). After freeze-drying the aqueous phase, 0.8 g (72%) of the indicated hydrochloride is obtained.
    Example 28. 6- - 2-Amino- -2- (p-acetoxyfe 5-yl) acetamido Jj penicillanoyl-oxymethyl-1,1-dioxopenyl-lanyloxymethyl-dimethylmalonate,
    A, 6- {D- 2- (1-Methyl-2-methoxycar-bonylvinylam-1; but) -2- (para-acetoxyphenyl) -acetamido penicillanoyl-oxymethyl-1, 1-dioxopenishlanoyloxy-oxymethyl dimethylmalonate.
     2- (1-Methyl-2-methoxycarbonyl
    vinylamino) -2- (para-hydroxyphenyl) -acetamido penicillanoyloxymethyl-1, 1-di.oc from penicillus anoyl to simetyl dime tilmalonate prepared according to example 27 (part A), 2.55 g (0.003 mol) and 4-dimethylaminopyridine (0.366 g)
    (0.003 mol) is dissolved in 30 ml of dimethyl chloromethane and 0.28 ml (AOOOZ mol) acetic acid / anhydride is added. The solution is stirred for 25 minutes,
    diluted to 100 ml, washed with water (30 mp), brine (30 ml), dried and concentrated to obtain 2.1 g (78%) of a yellow foam.
    B, the foam obtained by the method
    parts A, 2.1 g were dissolved in 50 ml of acetone and 23 ml of 0.1 N hydrochloric acid was added. After stirring for 20 minutes, the acetone is removed in vacuo and the aqueous layer is washed with ethyl ether.
    rum (2x30 mp), filtered through diatomaceous earth and freeze dried to obtain 1.77 (71%) of the indicated hydrochloride.
    Example 29, A, Repeat procedure using pivaloyl chloride instead of acetic anhydride, a non-purified product is obtained, which is chromatographically purified on 100 g of silica gel, eluted with a mixture of methylene chloride: ethyl acetate 60:40 (v / v). After concentration of the fractions containing the product, 2.3 g (82%) of a colorless foam which is 6- (1-methyl-methoxycarbonylvinyl21
    amino) -2- (para-pivaloyloxyphenyl) adhetamido penicillanoyloxymethyl -1 -1, 1-dioxapenicillanoyloxymethyl with CHM-methylmalonate.
    B. To 2.2 g (2.35 mol) of the enamine obtained in Part A in 24 ml of acetone is added 24 ml of O, 1 n hydrochloric acid. This mixture was stirred at ambient temperature for 5 minutes, the acetone was evaporated in vacuo and the aqueous residue was washed with ethyl ether (3 x 50 ml). The residual ester is removed from the aqueous layer, evaporating it in vacuo. The aqueous solution is made clear by filtration and freeze dried to obtain
     l, 61 g (80%). ) - 2-amino-2- (para-pivaloyloxyphenyl) acetamido penicyl lanoyloxymethyl-, 1-dioxopenicilloyloxymethyl-dimethylmalonate, hydrochloride.
    C, Using their formic-acetic anhydride as the acylating agent in Part A and removing the target group by the described method, 6- | D-2-amino-2- (para-forma-phyphenyl) acetamido J penicillanoyl-oxymethyl-1 is obtained , 1-dioxopenicillanoyl oximethyldimethylmalonate, hydrochloride.
    Example of OTO Benzyl-6- G) - (2- - (- methyl-2-methoxycarbonylvinylamino) -2-Fensch-acetamido penicillanoyl simethylglutarate.
    权利要求:
    Claims (2)
    [1]
    1, Benzylchloromethylglutarate.
    A mixture of 1.5 g (3.75 mmol) of tetrabutylammonium benzyl glutarate and 20 ml of methane chloride is stirred at room temperature for 3 hours and concentrated in vacuo to a viscous oil. This oil is placed in 20 ml of ethyl acetate and 30 ml of hexane and filtered to remove tetrabutylammonium iodide. The solvent is evaporated in vacuo and
    the residue is purified chromatographically on 45 D ° of resin. The resin is thoroughly ground.
    75 g of silica gel, eluting with a mixture of ethyl acetate: hexane 70:30 (by volume). Each min takes 15 ml fractions. The fractions containing the desired product (fractions 8-11) are combined and the solvent is evaporated in vacuo to give 0.55 g (62.5%) of the desired product.
    B. A mixture of 0.55 g (2 mmol) of benzyl chloroglutarate, 1.37 g (2 mmol) of tetrabutylammonium (1-methyl-2-methoxycarb onylvinylamino) -2-phenylacetamido penicillanate and 20 ml of acetone are mixed during the night
    05704
    at room temperature. The acetone is evaporated and the residue is purified by chromatography on silica gel, eluting with ethyl acetate: hexane 60:40 (v / v) to obtain 1.2 g (88%) of the product as an oil.
    Example 31. (2-Amino-2- -phenyl acetamido) penicillanoyloxy-10 methyl-1,1-dioxopenicillanoyl-oximethyldimethylmalonate-p-toluenesulfonate.
    A, 6- {D- 2- (1-Methyl-2-methoxy-carbonylvinylamino) -2-phenylacetamido 15 penicillanoyloxymethyl-1,1-dioxo-p-nicyllanoyloxymethyl dimethylmalonate.
    To 4.0 g (0.01 mol) sodium-1,1-dioxopenicillanoyloxymethyl dimethyl malonate and 6.0 g (0.01 mol) iodomethyl 20-b- (G) - 2- (1-methyl -2-methoxycarbonylvinylamino) -2-phenylacetamido-jne-nicillanate was added 40 ml of dimethylformamide. The resulting mixture was stirred at room temperature for 30 minutes. The mixture is poured into
    300 ml of ethyladetate, washed with water (4x100 ml), brine (1x100 ml), dried with Na.SOj and concentrated in vacuo to obtain 9.3 g of foam. The foam was purified by chromatography on silica gel (300 g), eluting with ethyl acetate: hexane 60:40, and the fractions were taken. 25 ml. Fractions 39-65 are combined and evaporated in vacuo to give 4.3 g (51%) of a brownish foam.
    B. To 30 MP of ethyl acetate, 0.836 g (1 mmol) of the enamine obtained in Part A was added, and the mixture was stirred until solution was obtained. A solution of 0.19 g (I mmol) hydrate
    p-toluenesulfonic acid in 5 ml of ethyl acetate is added to the mixture and stirred for 15 minutes, and the solvent is evaporated to a solid.
    with 150 ml of ethyl ether, stirred overnight, filtered, washed with ethyl ether and air dried to obtain 0.84 g (92%) of tosylate.
    Example 32. Sodium-1, 1-dio1 {- co-b-beta-hydroxymethylpenicillanoyl-methylmethyl adipate.
    A. A mixture of sodium-1,1-dioxo-6-beta-hydroxymethyl penicillanate (285 mg, 1 mmol) and equimolar amounts (1 mmol) of benzyl chloromethyl adipate and tetrabutylammonium bromide in 5 ml of acetone is heated under nitrogen atmosphere
    at reflux overnight. The acetone is evaporated, the residue is taken up in ethyl acetate and washed twice with water and dried (). After evaporation of the solvent in vacuo and careful trituration of the residue with chloroform, a crude product is obtained, which is chromatographed on silica gel, eluted with methylene chloride: ethyl acetate 4: 1 to obtain 410 mg (78%) of benzyl ester
    The benzyl ester is placed in 40 ml of ethyl acetate and hydrogenated on a 5% Pd / C catalyst at a pressure of 3.5 kg / cm hydrogen for 30 minutes. The catalyst is filtered off, washed with ethyl acetate. The filtrate is concentrated to a small volume and, with rapid stirring, 129 mg of sodium-2-ethylhexanoate in ethyl acetate are added. The precipitated product is filtered off, washed with ethyl acetate and air dried to obtain 199 mg. the title compound as a colorless solid.
    Example 33, Sodium-J, 1-dioxo-6-beta-hydroxymethylpenyl1-lanoyl-methylmethylglutarate.
    Using a mixture of 485 mg (1.7 mmol) 1.1 dioxo-6-beta-hydroxymethyl penicillanate, 450 mg (1.66 mmol) of benzylchloromethylglutarate and 548 mg (1.7 mmol) of tetrabutylammonium bromide in 5 ml of acetone, the corresponding benzyl ester (664 mg) according to the method described in Example 32. After hydrogenation on a Pd / C catalyst and converted to the sodium salt, 315 mg of the title compound is also obtained by the described method.
    Example 34, 1, l-dioxo-6-α-alpha-aminomethylpenicillanoyloxy-trans-1, 4-cyclohexane dicarbono-45 dinene was administered orally (5 rats each
    wa acid
    A, Tetrabutylammonium-1,1-dioxo-6-alpha- (benzyl xycarb onyl aminomethyl) penicillanate,
    100 ml of water and 0.142 g (1.69 mmol) of sodium bicarbonate are added to a solution of 0.67 g (1.69 mmol) of 6-α- (benzyloxycarbonyl aminometide) penicillanic acid 1,1-dioxide in 50 ml of methylene chloride; the mixture was adjusted to 8.0 with 1N sodium hydroxide. 0.573 g (1.69 mmol) of tetrabutylammonium bisulfate is added and the pH is again adjusted to 8.0 with 1 N hydroxide.
    on three . The mixture is stirred for 20 minutes, the layers are separated and the aqueous phase is extracted with 25 ml of methylene chloride. The combined organic layers are washed with brine, dried (KalBO) and the solvent is evaporated in vacuo to half salt in the form of a white foam 0.98 g,
    B, Benzyl-1, l-dioxo-6-alfa- (benzyl-hydroxycarbonyl-aminomethyl) penicyl-noyl-hydroxymethyl-trans-1, 4-cyclohexanide side of at.
    The product obtained in Part A
    (0.98 g, 1.53 mmol), and 0.476 g
    (1.53 mmol) of benzylchloromethyl-trans- - 4 1; iclohexane dicarboxylate is stirred in 50 ml of acetone at room temperature (under nitrogen atmosphere)
    within 17 hours. The mixture is concentrated in vacuo to an oil, which is purified by chromatography on 100 g of silica gel, eluting with ethyl acetate: chloroform 30:70 in
    15 ml fraction. Fractions (10-13) are combined and evaporated to obtain a 0.45 g colorless foam.
    . C. The product obtained in Part B, 0.45 g is combined with 0.5 g of 10% Pd / C
    catalyst in 20 ml of water and 20 ml of tetrahydrofuran and hydrogenated at 50 psi (3.52 kg / cm) for 15 min. The mixture was filtered, and the mixture was tetrahydrofuran-water and
    the resulting filtrate and the washings are evaporated in vacuo to a small volume. The remaining crystals are mixed with tetrahydrofuran and air dried to obtain 0.22 g (73.5%)
    said compound.
    Pharmacokinetic studies. Data on pharmacokinetics were obtained on rats weighing 80-100 g of Spraque-Dawley outbried strain, Test soles of each compound) in the form of an aqueous suspension containing 10 or 20 mg / kg of the preparation. Blood samples were taken at a specified time and subjected to differential bionalysis to determine ampicillin levels and penicillanic acid 1,1-dioxide penicillanic acid. Sarcina lutea (ATCC9341) was used in an ampicillin bioassay,
    Which is sensitive to ampicillin, but is insensitive to a beta-lactamase inhibitor in concentrations as high as 100 mg / ml, as it does not contain beta-lactamase. So
    plastic plates. The plates are then incubated for 18 hours, and the resulting zones are measured.
    The bioassay of amoxicillin and penicillin V is carried out in the same way, using standard curves obtained with the corresponding penicillin.
    The determination of salbactam is based on the insensitivity of Pasteurella histolytica (59B010) to high concentrations of either ampicillin or salbactam separately. However, since its stability is effected through beta-lactamase, the culture reacts synergistically for a combination of ampicillin and salbactam. Standard curves are prepared in a manner similar to that described for ampicillin. Assay plates are prepared by adding 1 ml of Pasteurella overnight culture. histolytica to 100 ml of Moller-Hinton agar, and to this add 50 µg / mp of ampicillin and 5% sterile bovine blood. The plates are incubated for about 18 hours in the leak, after which the zones are measured.
    The determination of 1-dioxide-6-beta-hydroxymethylpenicillanic acid and I, 1-dioxide-6-alpha-aminomethylpenicillanic acid is carried out in the same way.
    Pharmacological data for rats for oral administration of test compounds are given in the table (for P, AMP, AMOH, and Resch values correspond to ampicillin, amoxicillin, and penicillin V).
    From the data obtained, it follows that when the compound is taken orally, where pO and R-B, significantly higher blood levels of the inhibitor of the corresponding beta-lactamase, UNIF, are created.
    mul
    K.-С-О-СНоОС O.
    about
    And I
    K2 - ((OCH2)
    ABOUT
    where A is l-alkylene, group
    (he 3) 7 C, cyclohexylene or phenyl;
    R and h - are different and mean: at
    p O K - P or B (a, b and c) i 1 is hydrogen or basyl; with n 1 RI, - P, Hj
    wherein
    Ba, R - group
    40
    C HjOCHjCO
    or
    where Q is NHJ or 1-methyl-2-methoxycarboniuranyl; R is hydrogen or hydroxyl; B - group of formula
    V
    riCr,
    CH5
    27
    where X is hydrogen (Ba), (B),
    SN, №TS (Su),
    or a pharmaceutically acceptable alkali or quaternary ammonium salt thereof, characterized in that the compounds of the general formula
    P COOM or C COOM,
    where P is indicated above, excluding Q - amino group;
    B is indicated above when X is hydrogen CHjOH or C HjCHjOCOHHCH;
    M is sodium, potassium or tetrabutyl ammonium,
    subjected to interaction with the compound of the General formula
    LSNp
    A Ftg (COCH2)
    ABOUT
    A, n and R, j X
    above, halogen;
    R -SOOCH OSgO
    P
    R 4COCH)
    about
    ,,,,
    , (
    6-. /
    J
    9
    : CHj soon
    0428
    in medium K, K-dimethylformamide or ethyl acetate, or -dichloromethane, or acetone, at a temperature from room temperature to, and in the case when.X, is a benzyloxycarbonylamino group, and Q is a 1-methyl 2-methoxycarbonylvinylamino group, the last translation t to the amino group, followed by isolation of the desired product in free form or in the form of pharmaceutically acceptable alkaline or quaternary ammonium salts.
    [2]
    2. The method according to p. 1, characterized in that the process is conducted at 25 - 50 C.
    Priority featured:
    12.22.81 when R ,, RJ, A and p have the values listed in paragraph 1. formulas, with the exception of A - cyclohexylene, and EZ - 2,6-dimethoxyphenylcarbonyl or phenoxyacetyl;
    09.30.82pri, A - cyclohexylene; RJ is 2,6-dimethoxyphenylcarbonyl or phenoxyacetyl.
    类似技术:
    公开号 | 公开日 | 专利标题
    DE2713272C2|1983-01-20|Derivatives of 7-aminothiazolyl-acetamido-cephalosporanic acid, their preparation and pharmaceutical compositions
    DE2760287C2|1988-04-14|
    DK145157B|1982-09-20|ANALOGY PROCEDURE FOR PENICILLIN PREPARATION
    SU1405704A3|1988-06-23|Method of producing methylenedioldicarboxylated compounds or pharmaceutically acceptable alkali or quaternary ammonium salts thereof
    SU698532A3|1979-11-15|Method of preparing pyrido | pyrimidine derivatives
    CH669600A5|1989-03-31|
    SU886747A3|1981-11-30|Method of preparing cephalosporin compounds
    US4094978A|1978-06-13|3-propenyl derivatives of cephalosporin, compositions and their use
    US4578377A|1986-03-25|Derivatives of cephalosporins, their process of separation and antibiotic drugs containing the said derivatives
    DD285604A5|1990-12-19|PROCESS FOR THE PREPARATION OF ENOL ETHERS AND ESTERS
    SU1217261A3|1986-03-07|Method of producing 6-|penicillanoyloxymethyl-1,1-dioxopenicillanoylmethyl-carbonate or its acid-additive salt
    CA1072951A|1980-03-04|Reactive penicillanic acid and cephalosporanic acid derivatives and a process for the preparation thereof
    US3367948A|1968-02-06|Novel d-threo-1-phenyl-2-amino-propane-1, 3-diol-derivatives
    US4171303A|1979-10-16|Process for the preparation of reactive penicillanic acid and cephalosporanic acid derivatives
    JP3207017B2|2001-09-10|Method for producing benzylsuccinic acid derivative and intermediate for producing the same
    US4064137A|1977-12-20|Penicillin and cephalosporin derivatives and process for preparing the same
    SE505050C2|1997-06-16|Process for making cephem derivatives
    PL144812B1|1988-07-30|Process for preparing novel bis-esters of dicarboxylic acids
    PT92890A|1990-07-31|PROCESS FOR THE PREPARATION OF CEFALOSPORIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    SU410590A3|1974-01-05|
    US3681342A|1972-08-01|Esters of -carboxybenzylpenicillin
    EP0311521B1|1992-04-08|Cephalosporin derivatives with improved pharmacokinetics, process for their preparation, pharmaceutical compositions containing them and intermediate
    JPH07184685A|1995-07-25|Method for synthesizing optionally pure tetraquinoline derivative
    US3449336A|1969-06-10|Process for preparing novel intermediates useful for preparing 7-amino-cephalosporanic acid and derivatives thereof
    US4035502A|1977-07-12|Acylaminopenicillanic acids and process for preparing them
    同族专利:
    公开号 | 公开日
    ES524895A0|1985-02-01|
    RO87709B|1985-10-01|
    PL145927B1|1988-11-30|
    DK69092D0|1992-05-26|
    US4457924A|1984-07-03|
    JPH02270881A|1990-11-05|
    YU183084A|1986-10-31|
    PT76012A|1983-01-01|
    HU187737B|1986-02-28|
    IE54333B1|1989-08-30|
    DK69192A|1992-05-26|
    PL239651A1|1985-01-16|
    GR77066B|1984-04-05|
    EP0083484B1|1986-02-19|
    RO84911B|1984-09-30|
    DK565482A|1983-06-23|
    PH18311A|1985-05-29|
    IL67530A|1986-02-28|
    YU284482A|1985-03-20|
    ES8402310A1|1984-02-01|
    RO87709A|1985-10-31|
    ES518425A0|1984-02-01|
    IL67530D0|1983-05-15|
    ES8503001A1|1985-02-01|
    PL140291B1|1987-04-30|
    FI80039C|1990-04-10|
    BG50160A3|1992-05-15|
    CA1213582A|1986-11-04|
    BG50161A3|1992-05-15|
    YU43111B|1989-02-28|
    ES8530002A1|1985-02-01|
    BG50162A3|1992-05-15|
    RO84911A|1984-08-17|
    EP0083484A1|1983-07-13|
    ES524894A0|1985-02-01|
    NO824305L|1983-06-23|
    AU9172182A|1983-06-30|
    YU43992B|1990-02-28|
    BG48694A3|1991-04-15|
    NZ202670A|1985-12-13|
    DK69092A|1992-05-26|
    FI80039B|1989-12-29|
    PL248637A1|1985-02-27|
    GT198200058A|1984-06-09|
    FI824409L|1983-06-23|
    AU537214B2|1984-06-14|
    FI824409A0|1982-12-21|
    IE823034L|1983-06-22|
    DE3269267D1|1986-03-27|
    KR860001370B1|1986-09-17|
    PT76012B|1985-12-13|
    PL141306B1|1987-07-31|
    DD207379A5|1984-02-29|
    DK69192D0|1992-05-26|
    KR840002840A|1984-07-21|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    NL299897A|1962-11-02|
    US2985648A|1958-10-06|1961-05-23|Doyle Frank Peter|Alpha-aminobenzylpenicillins|
    US3520876A|1967-11-01|1970-07-21|American Home Prod|Process for the preparation of 6-penicillanic acids|
    ES436565A1|1974-06-05|1977-04-01|Bristol Myers Co|Enzymatic preparation of 6-d--' -amino-' -penicillin acid|
    FR2290443B3|1974-11-06|1977-08-05|Aries Robert|
    FR2309570A1|1975-04-29|1976-11-26|Aries Robert|POLYMERIC DERIVATIVES OF PENICILLINS AND CEPHALOSPORINS|
    GB1569421A|1976-06-11|1980-06-18|Beecham Group Ltd|Penicillin compositions|
    US4234579A|1977-06-07|1980-11-18|Pfizer Inc.|Penicillanic acid 1,1-dioxides as β-lactamase inhibitors|
    IE49881B1|1979-02-13|1986-01-08|Leo Pharm Prod Ltd|B-lactam intermediates|
    US4244951A|1979-05-16|1981-01-13|Pfizer Inc.|Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide|
    US4309347A|1979-05-16|1982-01-05|Pfizer Inc.|Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide|US4675186A|1985-04-18|1987-06-23|Pfizer Inc.|6-penicillanic acid derivatives|
    LU87821A1|1990-10-12|1992-05-25|Cird Galderma|BI-AROMATIC COMPOUNDS, AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS|
    DK0508943T3|1991-03-11|1995-01-30|Schweizerhall Saeurefab|Process for preparing halogenated carboxylic acid esters|
    DE59200877D1|1991-03-11|1995-01-19|Schweizerhall Saeurefab|Process for the production of chlorinated carboxylic acid esters.|
    US7553989B2|2002-10-18|2009-06-30|Meiji Seika Kaisha, Ltd.|Malonic acid monoesters and process for producing the same|
    KR101746250B1|2009-12-01|2017-06-12|스미또모 가가꾸 가부시키가이샤|Process for preparation of cycloalkanedicarboxylic acid monoesters|
    US7973194B1|2010-03-18|2011-07-05|Eastman Chemical Company|High solvating cyclohexane dicarboxylate diesters plasticizers|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US33402281A| true| 1981-12-22|1981-12-22|
    US06/429,915|US4457924A|1981-12-22|1982-09-30|1,1-Alkanediol dicarboxylate linked antibacterial agents|
    [返回顶部]